Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Emergent BioSolutions Inc., 3 years.
Emergent BioSolutions Inc.
Director · Chairman
Aptevo Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Emergent BioSolutions Inc. April 29, 202692.3%
-
Aptevo Therapeutics Inc. June 2, 202373.8%
-
Emergent BioSolutions Inc. May 25, 202391.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Aptevo Therapeutics Inc. | Option exercise | +400 | — | — |
| Apr 30, 2026 | Emergent BioSolutions Inc. | Grant or award | +25,344 | — | — |
| Jul 17, 2025 | Aptevo Therapeutics Inc. | Option exercise | +1 | — | — |
| Apr 30, 2025 | Emergent BioSolutions Inc. | Grant or award | +34,403 | — | — |
| Jun 2, 2024 | Aptevo Therapeutics Inc. | Option exercise | +81 | — | — |
| Jun 1, 2024 | Aptevo Therapeutics Inc. | Option exercise | +7 | — | — |
| May 23, 2024 | Emergent BioSolutions Inc. | Grant or award | +17,430 | — | — |
| Aug 9, 2023 | Aptevo Therapeutics Inc. | Option exercise | +3,571 | — | — |
| Jun 1, 2023 | Aptevo Therapeutics Inc. | Option exercise | +297 | — | — |
| May 25, 2023 | Emergent BioSolutions Inc. | Grant or award | +33,847 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.